Notably, platelet granules and mediators such as β thromboglobulin (βTG) and platelet factor 4 (PF‐4) are activated in MS (Dziedzic and Bijak 2019; Wachowicz et al. 2016). This evidence concerns the gene PF4 and myeloid sarcoma.